Compare LC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LC | AORT |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2008 | 1996 |
| Metric | LC | AORT |
|---|---|---|
| Price | $14.61 | $35.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $22.67 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 1.8M | 493.9K |
| Earning Date | 04-27-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 157.78 | ★ 165.62 |
| EPS | ★ 1.16 | 0.21 |
| Revenue | ★ $314,702,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | $15.91 | $11.17 |
| P/E Ratio | ★ $12.66 | $177.33 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $7.90 | $21.97 |
| 52 Week High | $21.67 | $48.25 |
| Indicator | LC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 34.71 |
| Support Level | $12.25 | $34.35 |
| Resistance Level | $17.41 | $44.29 |
| Average True Range (ATR) | 0.85 | 1.46 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 21.68 | 26.41 |
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.